We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+23.53%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$221M
AUM Growth
+$50.5M
Cap. Flow
+$20.5M
Cap. Flow %
9.26%
Top 10 Hldgs %
55.64%
Holding
119
New
19
Increased
16
Reduced
14
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 36.46%
2 Financials 19.6%
3 Materials 10%
4 Technology 8.95%
5 Industrials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$5.59B
$24.7M 11.16%
397,610
UPLD icon
2
Upland Software
UPLD
$13.9M
$18.7M 8.44%
40,650
FTAI icon
3
FTAI Aviation
FTAI
$20B
$16.4M 7.43%
819,700
APO icon
4
Apollo Global Management
APO
$79.7B
$14.7M 6.65%
300,000
DNMR
5
DELISTED
Danimer Scientific, Inc.
DNMR
$11.8M 5.32%
+12,500
New +$6.71M
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.19T
$9.81M 4.44%
112,000
CLMT icon
7
Calumet Specialty Products
CLMT
$4.2B
$8.28M 3.75%
2,645,000
+625,000
+31% +$2.18M
MDWT
8
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$7.71M 3.49%
+143,621
New +$8.29M
FSK icon
9
FS KKR Capital
FSK
$3.39B
$6.54M 2.96%
395,175
PFE icon
10
Pfizer
PFE
$159B
$4.41M 2%
119,900
-19,123
-14% -$701K
LKQ icon
11
LKQ Corp
LKQ
$6.46B
$4.23M 1.91%
120,000
-30,000
-20% -$1.03M
KKR icon
12
KKR & Co
KKR
$97.6B
$4.05M 1.83%
100,000
GILD icon
13
Gilead Sciences
GILD
$181B
$3.78M 1.71%
64,842
+53,842
+489% +$3.25M
KW
14
DELISTED
Kennedy-Wilson Holdings
KW
$3.76M 1.7%
210,000
EIGR
15
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.63M 1.64%
9,835
+657
+7% +$188K
ABBV icon
16
AbbVie
ABBV
$451B
$3.51M 1.59%
32,769
-5,000
-13% -$480K
VXX icon
17
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$133M
$3.36M 1.52%
+3,125
New +$4.06M
EBC icon
18
Eastern Bankshares
EBC
$5.09B
$3.26M 1.48%
+200,000
New +$2.84M
BMY icon
19
Bristol-Myers Squibb
BMY
$136B
$3.25M 1.47%
52,409
+6,000
+13% +$369K
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.12M 1.41%
42,614
+5,083
+14% +$378K
XENE icon
21
Xenon Pharmaceuticals
XENE
$5.81B
$3.08M 1.39%
200,000
+23,000
+13% +$269K
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
$2.91M 1.32%
702,000
+90,000
+15% +$355K
TGTX icon
23
TG Therapeutics
TGTX
$8.26B
$2.64M 1.2%
50,773
CAP.U
24
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
$2.58M 1.17%
+250,000
New +$2.55M
TRIL
25
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.57M 1.16%
174,699
-1,516
-0.9% -$21.9K

Similar funds

David M. Knott's Q4 2020 Portfolio in Review

As of Q4 2020, David M. Knott held 119 positions worth $221M, up 30% from $170M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott deployed $20.5M of net new capital in Q4 2020, opening 19 new positions and adding to 16 existing holdings. Its largest new stake was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.71M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 42% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was LKQ Corp, an estimated $1.03M trimmed.

  • David M. Knott's largest Q4 2020 buy was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.71M.
  • David M. Knott added most to Gilead Sciences in Q4 2020, an estimated $3.25M increase.
  • David M. Knott's biggest Q4 2020 reduction was LKQ Corp, cutting an estimated $1.03M.
  • David M. Knott fully exited Stericycle Inc in Q4 2020, selling an estimated $10.1M.
  • David M. Knott's ten largest holdings make up 56% of its $221M portfolio in Q4 2020.
  • David M. Knott opened 19 new positions and closed 9 in Q4 2020.
  • David M. Knott's portfolio value rose 30% quarter-over-quarter to $221M.

Based on David M. Knott's 13F filing for Q4 2020, filed 12 Feb 2021.